肯尼亚基利菲地区尽管补种活动效果减弱,疫苗型侵袭性肺炎球菌病仍持续减少:基于接种前数据的数学模型
该研究基于肯尼亚基利菲地区接种前数据和接种后监测,构建年龄结构隔室动态模型预测接种后十年肺炎球菌携带与侵袭性肺炎球菌病(IPD)。模型预测疫苗型携带率在婴儿和1-5岁儿童中均从33%和30%降至8%,IPD总体下降56%,疫苗型IPD下降83%而非疫苗型IPD上升52%。
要点
- 模型预测接种后十年婴儿疫苗型携带率从33%降至8%,1-5岁儿童从30%降至8%。
- IPD总体发病率下降56%,相当于每年每10万人减少10.4例。
- 疫苗型IPD下降83%,非疫苗型IPD上升52%,疫苗型血清型循环未被完全消除。
核心结论
- 模型预测通过肺炎球菌结合疫苗接种,IPD将持续大幅下降,但当前接种方案不足以完全消除疫苗型血清型循环。
- 尽管补种活动效果减弱,观察到的接种影响可能持续。
研究设计与样本
- 构建隔室、年龄结构动态模型,涵盖三个血清型组:10价疫苗血清型及根据相互竞争易感性划分的两个非疫苗血清型组。
- 模型以接种前时代年龄和血清型特异性携带与IPD数据进行校准,预测接种后十年携带率和IPD,并以接种后观察携带率进行验证。
主要发现
- 模型预测接种后十年婴儿疫苗型携带率从33%降至8%,1-5岁儿童从30%降至8%。
- IPD发病率预测在所有年龄组下降,总体人群下降56%,相当于每年每10万人10.4例。
- 疫苗型IPD发病率估计下降83%,非疫苗型IPD发病率预测上升52%。
- 模型对接种后前五年携带率的预测与观察数据吻合良好。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In 2011, Kenya introduced the 10-valent pneumococcal conjugate vaccine together with a catch-up campaign for children aged <5years in Kilifi County. In a post-vaccination surveillance study based in Kilifi, there was a substantial decline in invasive pneumococcal disease (IPD). However, given the continued circulation of the vaccine serotypes it is possible that vaccine-serotype disease may re-emerge once the effects of the catch-up campaign wear off. METHODS: We developed a compartmental, age-structured dynamic model of pneumococcal carriage and invasive disease for three serotype groups: the 10-valent vaccine serotypes and two groups of non-vaccine serotypes based on their susceptibility to mutual competition. The model was calibrated to age- and serotype-specific data on carriage and IPD in the pre-vaccination era and used to predict carriage prevalence and IPD up to ten years post-vaccination in Kilifi. The model was validated against the observed carriage prevalence after vaccine introduction. RESULTS: The model predicts a sustained reduction in vaccine-type pneumococcal carriage prevalence from 33% to 8% in infants and from 30% to 8% in 1-5year olds over the 10-year period following vaccine introduction. The incidence of IPD is predicted to decline across all age groups resulting in an overall reduction of 56% in the population, corresponding to 10.4 cases per 100,000 per year. The vaccine-type IPD incidence is estimated to decline by 83% while non-vaccine-type IPD incidence is predicted to increase by 52%. The model's predictions of carriage prevalence agrees well with the observed data in the first five years post-vaccination. CONCLUSION: We predict a sustained and substantial decline in IPD through PCV vaccination and that the current regimen is insufficient to fully eliminate vaccine-serotype circulation in the model. We show that the observed impact is likely to be sustained despite waning effects of the catch-up campaign.
引用
- Ojal J, Flasche S, Hammitt LL, et al. Sustained reduction in vaccine-type invasive pneumococcal disease despite waning effects of a catch-up campaign in Kilifi, Kenya: A mathematical model based on pre-vaccination data. Vaccine. 2017. PMID: 28729018. doi:10.1016/j.vaccine.2017.07.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。